Laboratory studies suggest that CS inhibits the transcription factor nuclear factor kappa B (NFkB) from translocating to the nucleus [40,42], a key factor in many inflammatory processes, including atherosclerosis. The gene discussed is NFKB1; the disease is atherosclerosis.